Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer

BACKGROUND: Studies conducted in Swedish populations have shown that men with lowest prostate-specific antigen (PSA) levels at ages 44–50 years and 60 years have very low risk of future distant metastasis or death from prostate cancer. This study investigates benefits and harms of screening strategi...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Natl Cancer Inst
Main Authors: Heijnsdijk, Eveline A M, Gulati, Roman, Tsodikov, Alex, Lange, Jane M, Mariotto, Angela B, Vickers, Andrew J, Carlsson, Sigrid V, Etzioni, Ruth
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566340/
https://ncbi.nlm.nih.gov/pubmed/32067047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa001
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍